Page 4 - Daniel Altmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Findings suggest boosting antibodies can compensate for jabs being less well matched than to earlier variants

From pandemic to epidemic | Briefing

New research into treatment and diagnosis of long COVID 15 new studies across the UK will expand research into long COVID to support thousands of vulnerable people, backed by nearly £20 million through the NIHR From: 15 new studies across UK to expand research that will support thousands of vulnerable people Nearly £20 million for research projects will help improve understanding of long COVID and identify effective treatments Projects include the largest long COVID trial to date which will involve over 4,500 people Thousands of people suffering with long COVID will benefit from new res...

Sputnik V Gives 90% Protection Against Delta Strain of COVID-19, Scientist Says © AP Photo / Pavel Golovkin Subscribe Sputnik International https://sputniknews.com/world/202107111083358953-sputnik-v-gives-90-protection-against-delta-strain-of-covid19-scientist-says/ NOVOSIBIRSK (Sputnik) - Viral vector and mRNA vaccines, including Russia’s Sputnik V, provide enough protection against the new Delta strain of the coronavirus, Head of the Novosibirsk State University’s Laboratory and corresponding member of the Russian Academy of Sciences (RAS) Se...

Recent studies have published encouraging findings around immunity So far, more than 45 million of us have had a first dose of a Covid-19 vaccine dose - about nine in 10 of the adult population – and more than 33 million people in the UK have had a second. This magnificent national effort is now paying dividends. Despite rising case numbers, the proportion of people ending up in hospital after infection is much smaller than in previous waves. But now attention is turning to the next big issue: How long will immunity last? Concerns about waning antibody levels and the efficacy of current vac...